Between July 7, 2023, and June 30, 2024, Houston-based University of Texas MD Anderson had the lowest rate of Clostridioides difficile infections among cancer hospitals exempt from reporting to Medicare’s Inpatient Prospective Payment System.
Eleven PPS-exempt cancer hospitals are required to participate in the PPS-Exempt Cancer Hospital Quality Reporting Program, a specialized quality reporting program established in 2010 by the ACA.
Healthcare associated infections are measured by a standard infection ratio, which compares the observed number of infections to the number of predicted infections.
All 11 PPS-exempt cancer hospitals reported C. diff infection rates under the national C. diff infection rate.
Here are the C. diff infection rates of PPS-exempt cancer hospitals between July 7, 2023, and June 30, 2024, according to CMS data:
- University of Texas MD Anderson Cancer Center (Houston): 0.237
- University of Miami Sylvester Comprehensive Cancer Center: 0.38
- Moffitt Cancer Center (Tampa, Fla.): 0.382
- Memorial Sloan Kettering Cancer Center (New York City): 0.437
- The James Cancer Hospital and Solove Research Institute (Columbus, Ohio): 0.453
- Fox Chase Cancer Center (Philadelphia): 0.598
- Roswell Park Cancer Institute (Buffalo, N.Y.): 0.694
- Dana-Farber Cancer Institute (Boston): 0.711
- USC Kenneth Norris Jr. Cancer Hospital (Los Angeles): 0.796
- Fred Hutchinson Cancer Institute (Seattle): 0.874
- City of Hope (Duarte, Calif.): 0.877
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
